The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by ...

Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients, Mitsubishi ...

Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to ...

Living close to cyanobacterial harmful algal blooms in U.S. water bodies is associated with increased risk of mortality from ...

When Mindy Uhrlaub got tested to see if she was a carrier of the fatal mutation that causes the amyotrophic lateral sclerosis ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.

The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.